U.S. Advanced Wound Care Market Size, Share, Growth and Trend Analysis Report, 2019 to 2026Drugs & MedicationsUpdated on Feb 14, 2020 View more like this | Visit NEW YORK, NY | Contact Grand View Research, Inc. |
The U.S. advanced wound care market is expected to reach USD 3.42 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.2% over the forecast period. Rising number of surgeries and increasing incidence of chronic wounds in the U.S. are the key factors driving the market.
In the recent past, there has been a rise in the number of surgical procedures in the U.S. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. Incidence of infectious and non-communicable diseases has increased over the past few decades. This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rise in prevalence of food-borne diseases. Unhealthy lifestyle, limited physical activity, alcohol abuse, and smoking are some of the major factors contributing to rising prevalence of the abovementioned diseases. According to CDC, in 2017, more than 100.0 million people were living with diabetes in the U.S.
Type II diabetes is the most common type of diabetes, and 90% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires surgical intervention to prevent foot amputation. Thus, increasing number of surgeries is expected to drive growth of the advanced wound care market in the U.S. Cancer is a major healthcare burden in the U.S., as it is the second leading cause of death. According to CDC, about 1,658,716 new cases of cancer were reported in the U.S. in 2016. Therefore, these factors are likely to expedite market growth.
Further key findings from the report suggest:
Access full research report on U.S. advanced wound care market: www.grandviewresearch.com/industry-analysis/us-advanced-wound-care-market
In the recent past, there has been a rise in the number of surgical procedures in the U.S. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. Incidence of infectious and non-communicable diseases has increased over the past few decades. This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rise in prevalence of food-borne diseases. Unhealthy lifestyle, limited physical activity, alcohol abuse, and smoking are some of the major factors contributing to rising prevalence of the abovementioned diseases. According to CDC, in 2017, more than 100.0 million people were living with diabetes in the U.S.
Type II diabetes is the most common type of diabetes, and 90% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires surgical intervention to prevent foot amputation. Thus, increasing number of surgeries is expected to drive growth of the advanced wound care market in the U.S. Cancer is a major healthcare burden in the U.S., as it is the second leading cause of death. According to CDC, about 1,658,716 new cases of cancer were reported in the U.S. in 2016. Therefore, these factors are likely to expedite market growth.
Further key findings from the report suggest:
- In terms of revenue, foam dressing segment held the largest share in 2018 owing to the rising incidence of chronic wounds
- In the application segment, chronic wound segment is expected to witness the fastest growth rate over the forecast period owing to rising incidence of diabetes in the U.S.
- Home healthcare segment is expected to witness fastest growth over the forecast period due to the increasing number of surgeries in the U.S.
- Prominent key players present in the U.S. advanced wound care market are Smith & Nephew, Molnlycke Health Care AB, and Baxter.
Access full research report on U.S. advanced wound care market: www.grandviewresearch.com/industry-analysis/us-advanced-wound-care-market
